No Data
No Data
SAB Biotherapeutics Is Maintained at Buy by Chardan Capital
Express News | HC Wainwright & Co. Reiterates Buy on SAB Biotherapeutics, Maintains $6 Price Target
SAB Biotherapeutics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Sandoz Group Ltd (OtherSDZXF) and SAB Biotherapeutics (SABS)
Express News | SAB Biotherapeutics Shares Are Trading Lower After the Company Reported Worse-than-expected Q2 EPS Results
SAB Biotherapeutics GAAP EPS of -$0.79
No Data